The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Ahead of its merger with Newark-headquartered Gibbons PC, national law firm Frost Brown Todd LLC is tapping an industry veteran to lead financial operations. The firm welcomed Madhav Srinivasan as ...

Lance Nutt of FBT Bank and Mortgage (FBT) has been named to the Arkansas Bankers Association’s (ABA) inaugural Emerging Leaders Section. Nutt is executive vice president and director of lending ...

FBT selects 30 biotechnology stocks based on sales, sales as a percentage of R&D expenditures, and R&D growth compared to three years ago. The ETF launched 19 years ago and has delivered exceptional ...

In trading on Friday, shares of the First Trust NYSE Arca Biotechnology Index Fund ETF (Symbol: FBT) entered into oversold territory, changing hands as low as $161.895 per share. We define oversold ...

Family-based treatment (FBT) is the current leading recommended intervention for adolescents with eating disorders. As this treatment has certain limitations, alternative approaches are needed. The ...